In the course of screening actinomycetes for agents with differential solid tumor activity, U-77863 and U-77864 were isolated from Streptomyces griseoluteus, strain WS6724. Chromatography of extracts of the clear beer and mycelia yielded two pools ofeluate that were found to be active in vitro in the Wayne State University two-tumor soft agar assay.1}
The first pool of fractions, 6724A, yielded /ya7w-3-(2'-methylphenyl)-2-propene-l-carboxamide (U-77863) (I, Fig.  1 ) and the second, 6724B, yielded 3-hydroxy-3-(2'-methylphenyl)-propane-lcarboxamide (U-77864) (II). U-77864 was found to be a novel structure while a structure corresponding to U-77863 was reported to have been synthesized.2) However, the analytical results reported in that paper did not match those obtained for U-77863. Synthesis was used to confirm both structures and to provide sufficient quantities of each for further biological studies. Wereport the results of in vitro two-tumor assays of these compounds,as well as preliminary results of in vivo testing for toxicity and antitumor activity. Because of their relatively low toxicity and their structural characteristics, U-77863 and U-77864 were tested in the membrane invasion culture system (MICS), an in vitro model for measuring the ability of tumor cells to invade through reconstituted basement membranematrices and these results are included here.3)
Results

Isolation,
In Vitro Anti-tumor Activity, and Identification Fermentations of the culture, WS-6724, were found to exhibit differential solid tumor activity in vitro (Table 1 ) and produced activity versus P388 leukemia in vivo (%T/C 155 at a 1 : 3 dilution of the whole beer, 1 ml injected ip, QID x 5, in BO1mice). This culture was isolated from a soil sample of unknown origin. Comparisons of the Ektachrome photographs and electron micrographs of this strain with those ofNRRLB-1315 and NRRL3412 were made. This strain exhibited an aerial mass color of white to sparse grayish-pink, was melanin-negative, showed good growth at 28°C and no growth at 50°C, and gelatin -CB  10  l x  500  -450  -900  -6724A  10  1/4  x  125  -370  -480  -6724B  10  1/10  x  50  70  -450  --U-77863  10  l x  500  50  ---0  U-77864  10  l x  500  0  ---0  Acrylamide  10  l x  500  1 30  -90  --Cinnanamide  10  1 x  500  ----0  4-Methylcinnanamide  1 0  1/2 x  250  0  --0  -III  10  1 x 500 0 --0 - liquefaction. From these studies, it was concluded that this culture is a strain identified as Streptomycet griseoluteus, strain WS6724. Extraction of the clear beer at basic pH (8.0 ] and the mycelia with «-butyl alcohol after filtration in the presence of filter aid and subsequent evaporation of the extract recovered the majority of the activity present in the whole and clear beers of this fermentation ( Table 1) . Chromatography of the combined concentrated extracts on silica gel with a mobile phase of toluene -methyl isobutyl ketone (MIBK) -methyl alcohol yielded only two pools of fractions which upon evaporation showed activity in the two-tumor assay. The first, 6724A, showed essentially equal activity against leukemia and solid tumor cells while the second, 6724B, showed differential activity toward solid tumor cells.
The structures of the compounds isolated from pools 6724A and 6724B (U-77863 and U-77864, respectively) were determined by chemical, spectroscopic, optical rotation, and X-ray diffraction analyses. U-77863 was determined to be of the trans configuration by *H NMRspectroscopy due to the coupling constant (16 Hz) for the vinylic hydrogens.4) As mentioned previously, a structure corresponding to that of U-77863 was reported, but the only data for the previously synthesized structure that was identified as 2'-methyl-3-phenylpropene-l-carboxamide was a melting point of 178°C.3) Their reference to a reported melting point of 179°C for this structure,5* was not supported by our inspection of that article. Wehave found the corrected melting point of 2'-methyl-3-phenylpropene-l-carboxamide to be 151~153°C. An optical rotation, [a]£5 = 0°, suggested that U-77864 consisted of a racemic mixture of the two stereoisomers generated by the chiral^-carbon. The X-ray diffraction spectra (Fig. 2 ) of U-77864 recrystallized from methyl alcohol confirmed that structure.
After recrystallization from MIBK,neither of the compounds isolated from the pools, 6724Aand 6724B (U-77863 and U-77864, respectively) showed significant activity in vitro in the Wayne State University two-tumor assay, but did produce activity in a modified two-tumor assay (Table 2)6) that was comparable to that shown for the evaporated pools, 6724A and 6724B. Both structures showed insignificant activity in the L1210 tube dilution assay (Table 3 ).7) The supernatants from these recrystallizations did not produce any other active structures. Wehypothesize that these compoundsare more solubilized in the in vitro cells system of the modified two-tumor assay than in the WayneState University two-tumor soft agar assay.
Synthesis of U-77863 and U-77864
A modified Perkin reaction involving o-tolualdehyde, acetamide, and potassium acetate produced U-77863 in 27% yield (Scheme 1, Fig. 3 ).8) The synthetic route to U-77864 (Scheme 2) involved the condensation of o-toluoyl chloride with ethyl acetoacetate in isopropyl alcohol -water (1 : 1) yielding III in 50% yield.9) The jS-ketoester was reduced with sodium borohydride to IV in 70% yield.10) This /Miydroxy ester was then converted to U-77864 in 27% yield with excess NH4OHin pyridine.11} A sample of the synthesized U-77864 was then converted to U-77863 in 64% yield by refluxing for 66 hours with /7-toluenesulfonic acid in toluene (Scheme 3).12) Dehydration did not occur under milder conditions. Spectroscopic (mass, NMR,IR and UV) and elemental analyses verified that the synthetic compounds were identical to those isolated from the beers.
In Vivo Antitumor Activity Both structures were non-toxic (lethality) in mice at single doses <400mg/kg (U-77863) and < 800mg/kg (U-77864) with ip administration. The higher non-lethal doses produced a central nervous system (CNS) stupor (i.e., extremely low heart and respiratory rates and almost no response at all to reflex stimuli). Flavone acetic acid (FAA, NSC-347512), (V) was reported to have produced analogous results.13) U-77863 and U-77864 were tested in vivo against P388 leukemia (Q4D x 3; ip tumor, ip drug), B16 melanoma (QID x 9; ip, ip), and Lewis lung carcinoma (QID x 9; ip, ip). Both U-77863 and U-77864 were inactive in those studies up to total doses of 400 and 800mg/kg, respectively.
Invasion Assay
Anobvious criteria for a true antiinvasive or antimetastatic effect was that the compounds should be active without killing tumor cells. Because of the low toxicity of U-77863 and U-77864 in the in vitro and in vivo antitumor assays, they were submitted for testing in the MICS. Toxicity was further evaluated in vitro in clonogenic colony formation assays. U-77863 powder was dissolved in DMSOat a concentration of 100~500mg/mlimmediately prior to each experiment. Drug was added to tissue culture mediumor partially diluted in Hank's balanced salt solution before being added to cells. Final concentrations of DMSO were all less than any which cause effects on clonogenicity, growth, and/or invasion. Treatment of K1735-M2 and B16-F10 cells did not decrease clonogenicity at doses <200jUg/ml.
A dose-dependent inhibition of invasion was seen for both murine melanoma cell lines (Table 4 ). In the first experiments, 98% inhibition of invasiveness in the MICSwas observed following pretreatment with 12.5 /xg/ml U-77863 for 48 hours. This value varied from 42~90% inhibition in subsequent experiments with the average IC50 for both cell lines between 5 and 10jUg/ml with a 48-hour exposure. Similar experiments with humanmelanomaand rat mammary adenocarcinoma cell lines show that inhibition Table 5 . Experimental metastasis formation by murine of invasion is greater if the cells are exposed for longer times. 14)
Results for other compoundsthat were initially tested using the same procedures as those used for U-77863 are also included in Table 4 . U-77864 and FAAwere inactive at the non-toxic doses selected. U-2422 (VII) and U-54 14 (VIII) produced significant antiinvasive activity. DEC. 1992 Metastasis Assay Initial in vitro results indicated that U-77863 could inhibit a key component of the metastatic process, "invasion". Pretreatment of B16-F10cells for 48-hour prior to tumor cell injection resulted in a slight dose-dependent inhibition of lung and extrapulmonary colonization in syngeneic C57BL/6mice (Table 5) . That there was any effect at all is remarkable since tumor had to grow, invade locally, and then complete the remaining steps in the metastatic process. Nonetheless, these experiments suggested that U-77863 had a relatively long-acting, statistically significant, inhibitory effect on the number of metastases under these stringent conditions. Interestingly, primary tumor growth was not affected by pretreatment with U-77863.
A more direct measure of effectiveness was assessed using the experimental metastasis assay and K1735 melanoma cells. Pretreatment for 48 hours with U-77863 resulted in a dose-dependent inhibition of the number of lung colonies formed in syngeneic C3Hmice following intravenous injection of 5 x 104 cells (Table 5) . Similar experiments with humanmelanoma cells revealed a dose-dependent, statistically significant inhibition as well. These in vivo and the previously described in vivo results have been confirmed in humanand rat tumors, and potential mechanisms for the antiinvasive and antimetastatic activity of U-77863 are being studied.14)
Experimental
General
Corrected melting points were obtained using the Mettler FP62 melting point apparatus and melting curves for standard materials.
Infrared data was obtained using a DIGILAB Model FTS15E
spectrophotometer. Nuclear magnetic resonance data, *H and 13C, were obtained on a Bruker 200 MHz spectrometer. Elemental analyses were obtained using a Perkin-Elmer Model 240B elemental analyzer.
Isolation of U-77863 and U-77864
Filter aid (5% w/v) was added to the whole beer from fermentation culture, WS-6724, and the resulting suspension was filtered in vacuo. Extraction of the clear beer (4.0 liters) at natural pH (8.0) and the mycelia with H-butyl alcohol (4 x 2,000 ml and 4 x 1 ,000 ml, respectively) and subsequent evaporation in vacuo of the combined extracts yielded 7.68 g of solid material. Chromatography of this solid material over 800 g of Silica Gel 60 (230 -400 mesh) with toluene -methyl isobutyl ketone (MIBK) -methyl alcohol (65 : 25 : 10) as mobile phase was initiated. The initial 950ml of eluate was discarded and 20ml fractions were collected at a rate of 2 ml/minute. The individual fractions of eluate were combined into pools based upon TLC (Analtech Silica Gel GF, 250 plates, toluene-MIBK-methanol, 65 : 25 : 10) and visualization under UVillumination of representative fractions. After evaporation in vacuo, the first pool, fractions 76~93, yielded 0.29 g of white, apparently crystalline solid designated as 6724A. The second pool, fractions 1 12~183, yielded 0.49 g of a second, white, apparently crystalline solid designated as 6724B. Subsequent recrystallization of each of these solids from MIBKyielded 0. 16 g of further purified solid from the 6724A pool and 0.26g of further purified solids from the 6724B pool. Portions of each of these solids were analyzed chemically and spectroscopically and the structures of the solids from 6724A and 6724B were identified as U-77863 and U-77864, respectively. A portion of the solids from 6724B which had been recrystallized from MIBKwas further recrystallized from methyl alcohol and submitted for X-ray diffraction spectroscopy. This further confirmed the structure of U-77864.
Tumor Cell Selection and Clonogenicity The B16-F10 melanoma cell line, syngeneic to the C57BL/6 strain, was selected for high lung colonization and is widely used in the study of metastasis.15) The K1735-M2cell line is a clone selected from a lung metastasis from the K1735 melanoma in syngeneic C3H mice.16) U-77863 was added to tumor cells which had been plated at least one day previously. After treatment 
MICSInvasion Assay
Invasion was quantified using the MICSwith minor modifications. Using a 24-well manifold chamber fitted with a silicone gasket, a 1 0-/im pore polycarbonate filter coated with reconstituted basement membrane (Matrigel) was placed between the upper and lower chambers of MICS. A single cell suspension of K1735-M2or B16-F10 cells was placed into the upper wells. After 72 hours, the cells were collected from the lower chamber using a 0.125% trypsin/2mM
EDTA solution in calcium-and magnesium-free Dulbecco's phosphate buffered saline. Invasion was determined by counting the cells after they had been separated from the liquid using a 3-^mpore polycarbonate filter. Data are reported as the numberof invading cells per high power field.
Metastasis Assays
Metastasis can be measured in two ways. The first, called the spontaneous metastasis assay, involves injection of tumor cells into a site where a primary tumor will grow. Tumorcells must then invade from the primary tumor, enter the vasculature or lumphatics, travel to distant sites and form a secondary tumor. The second assay, called the experimental metastasis assay, bypasses the first steps of tumor growth to assesses the ability of blood-borne tumor cells to form colonies. In the experimental metastasis assay, tumor cells are injected directly into the vasculature. In the B16 and K1735melanoma model systems, results are analogous. To evaluate the effectiveness of U-77863 on tumor growth and metastasis, B16-F10 melanomacells were tested in the spontaneous metastasis assay. Lungcolonization of K1735-M2 cells was evaluated in the experimental metastasis assay.
Murine melanoma cells were pretreated for 48 hours with U-77863. Subconfluent (70~90%confluence) K1735-M2 (a generous gift of Dr. I. J. Fidler, University of Texas, M. D. Anderson Cancer Center) cells were detached by removal"of medium followed by addition of 1 ml of 2mMEDTA. Whenthe cells began to retract, the plates were tapped to dislodge the cells. Ice-cold mediumwas added to dilute the EDTA. Cells were pelletted by centrifugation, the mediumremoved and the cells resuspended in ice-cold Hank's balanced salt solution (HBSS) at a concentration of 2.5 x 105 cells/ml. Cells (5 x 104) were injected into the lateral tail vein. Twoweeks later, the mice were killed and the lungs removed. Surface lung colonies were counted as previously described.
Subconfluent B16-F10cells were prepared as above except that they were suspended at a concentration of 5 x 106cells/ml. Cells (1 x 106) were injected into the dorsolateral flank. After 25 days, the mice were killed and subjected to a complete gross necropsy. Surface lung metastases were counted and the incidence of extrapulmonary metastases recorded. Extrapulmonary metastases were observed in adrenal glands, diaphram, liver and ovary.
Synthesis of U-77863 (I)
To 500ml pyridine (Mallinckrodt #7180) was added 33 g (840mmol) NaNH2 and 26.5 g (265mmol) diacetamide (Aldrich #D5959, lot AP022226DK) followed by dropwise addition of 25g (210mmol) 0-tolualdehyde (Aldrich #1 1,755-2 lot NM02306 TJ). After refluxing for 20 hours, the mixture was stirred in 1,000ml H2O. This mixture was extracted with 3 x 500ml CHC13and the extract evaporated, yielding 14.6g solid material. The solid was dissolved in 500ml CHC13 and extracted with 3 x 250ml 2.0n NaOH. The residual CHC13 phase was evaporated, yielding 9.3g (27%) of pure product; mp 151~153°C; TLC Rf0.38, toluene-MIBK-CH3OH (65 : 25 : 10); UV /l^Hnm (e) 208 (17,320), 220 (14,900), 225 sh (12,030), 276 (16,540); IR vmax (mineral oil) cm ' 1 1668.3, 2925.0, 1610.5, 2953.8, 2854.5, 3380.1, 1635.5, 2869.0, 1399.2, 3185.3, 753.1, 627.7, 976.8, 726.0, 1485.0, 1459.0, 677.0, 971.0, 1379.0, 3292.3, 1447.5, 1249.7, 954.6, 1286.5, 1137.8 H 6.88, N 8.69. Found: C 74.01, H 6.90, N 8.50. Synthesis of III DEC. 1992 To a stirred solution of 140ml (1,290mmol) ethyl acetoacetate (Aldrich #E964-1) in 2,000ml of isopropyl alcohol-water (1 : 1) maintained at <5°C in an ice bath, 288ml (2,380mmol) NaOH, 33% w/w, and 200g (1,290mmol) of o-toluoyl chloride (Aldrich #12, was added dropwise simultaneously from dropping funnels over 1 hour. The bath was removed and the contents heated to 35°C for 20 hours after which 129 g (2,400 mmol) NH4C1(Aldrich #21,333-0) was added. After an additional 24 hours stirring at 35°C, the mixture was concentrated to approximately 1 liter, and extracted with 3 x 500ml hexane. The hexane extract was evaporated to yield 169 g (64%) of liquid product; Rf 0.50 (TLC, ); UV^Hnm (e) 250 (19,830), 246 (9,750) 279 (3,330) ; IR vmax (mineral oil) cm ' 1 1742.5, 1688.5, 1193.8, 1260.3, 1202.5, 1319.2, 1300.0, 1289.3, 1034.7, 1626.8, 1149.5, 1641.3, 1410.8, 758.0, 1229.5, 1457.1, 1166.8, 770.5, 1382.8, 1367.5, 1601.7, 1136.0, 2482.0, 1446.5, 651.8 
Synthesis of IV
To a stirred mixture of 62g (1.63mol) NaBH4 (Al fa #14121) in 1,500ml hexane, 169g (815mmol) U-78720 in 250ml hexane was added dropwise over 15 minutes and the mixture was refluxed. After 22 hours, 2,000ml water was added cautiously and stirring continued until all the solids had degraded. The phases were separated, the aqueous phase was extracted with 2 x 1 ,000 ml hexane, and the combined hexane extracts were evaporated, yielding 1 18 g (69%) of product; Rf 0. 140.777, 134.234, 130.734, 127.458, 126.311, 125.292, 66.966, 60.787, 42.294, 18.919, 14.122 
Synthesis of U-77864 (II)
To 6.0g (29mmol) of U-89901 was added 20ml (290mmol) concentrated NH4OHwith stirring. Absolute ethanol (15 ml) was added to clarify the stirring mixture. After 17 hours stirring this mixture at room temperature, TLC (Analtech Silica Gel GF, 250 plates, toluene -MIBK-methanol, 65 : 25 : 10) showed U-77864 to be the major component. The mixture was evaporated, added to 200ml CC14, stirred, and filtered. The filtered solids were extracted with 3 x 100 ml CH3OH,filtered, and the filtrate was evaporated, "1 2918.3, 2954.9, 2854.6, 1675.2, 2868.1, 3351.3, 1461.1, 1455.3, 1057.0, 613.4, 1619.2, 3180.6, 766.7, 728.1, 641.3, 1378.1, 666.4, 1410.0, 1312.6, 698.2, 888.2, 1120.6, 1484.2, 1366.6, To a 500ml flask fitted with a water trap and nitrogen purge was added 0.5g (2.8mmol) U-77864, 0.54 g (0.28 mmol)/?-toluenesulfonic acid, monohydrate (Aldrich #T3, FW= 190.22, 99%) , and 250 ml of toluene and the mixture was stirred at room temperature for 6 hours with no reaction occurring. Subsequently, this mixture was stirred at reflux for 66 hours when TLC(Analtech Silica Gel GF, 250
plates, toluene-MIBK-methanol, 65:25: 10) showed the reaction to be complete. The solvent was evaporated and the residue extracted with 3 x 250ml CHC13.The extract was filtered and evaporated, yielding 0.287 g (64%) of the product.
Discussion
Neither U-77863 nor U-77864 produced significant differential solid tumor activity in vivo. However, the very significant in vitro antiinvasive activity and the in vivo antimetastatic activity of U-77863and the apparent lack of activity for U-77864 suggest that both may be very important leads in the development of antiivasive and antimetastatic therapies. In addition, the induction of the CNSstupor in mice, analogous to FAA, as well as the low lethal toxicity may be a significant discovery. Correspondingly, taxonomic studies found that another strain of Streptomyces griseoluteus produced the piperazinedione, 593A, (IX), 1 7) and Streptomyces ardus which produced porfiromycin (X) and mitomycins A and C (XI), also produced cinnamic acid amide.18) These observations, the previously unrecognized antiinvasive and antimetastatic activity, and the other activities described herein suggest that U-77863 and U-77864 may be involved in the biosynthetic pathways that produce some antitumor agents, are important leads in the development of antiinvasive/antimetastatic compounds, and maycontribute to a better understanding of antitumor and CNSactivity.
